Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting.
暂无分享，去创建一个
L. Cuzin | F. Raffi | L. Hocqueloux | V. Joly | J. Reynes | R. Palich | A. Cabié | O. Robineau | D. Rey | I. Lamaury | C. Allavena | C. Duvivier | C. Deschanvres | F. Bani-Sadr